|
A.
Nebistar (nebivolol) belongs to beta-blocker group of drugs and is no longer recommended for use as first line therapy in controlling blood pressure due to its adverse effect on blood lipids. It should be particularly avoided in young, sexually active males because of the risk of impotence.
The first line, drug of choice in young patients (below the age of 55 years) is enalapril (sold under trade names of BQL, Enam etc). Initially 5 mg single dose is generally adequate.
|